Zuclopenthixol dihydrochloride for schizophrenia-Reference-Cited by-同舟云学术

Zuclopenthixol dihydrochloride for schizophrenia

Published:2017-11-16 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bryan Edward J¹,Purcell Marie Ann²,Kumar Ajit³

Affiliation:

1. NHS Foundation Trust; Sheffield Health and Social Care; Fulwood House Old Fulwood Road Sheffield UK S10 3TH

2. Market Surgery; General Practitioner; Warehouse Lane Wath Rotherham UK S63 7RA

3. Leeds Community Healthcare NHS Trust; Child and Adolescent Mental Health Service; Leeds UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference157 articles.

1. Serum levels of the isomers of clopenthixol in patients given cis(Z)-clopenthixol or cis(Z)-trans(E)-clopenthixol;Aaes-Jorgensen;Acta Psychiatrica Scandinavica Supplementum,1981

2. Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence;Arango;European Psychiatry,2006

3. Antipsychotic treatment adherence and violence in schizophrenia outpatients: a randomized prospective trial;Bombin;European Neuropsychopharmacology,2004

4. A double blind multicentre comparison of oral zuclopenthixol and oral chlorpromazine in the treatment of acute psychosis;Balasubramanian;British Journal of Clinical Research,1991

5. Comprehensive clinical studies with thiothixene;Ban;Diseases of the Nervous System,1975

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of stability-indicating HPLC method for quantification of pharmacopeia impurities of Zuclopenthixol and characterization of its stress degradation products by LCMS/MS;Future Journal of Pharmaceutical Sciences;2023-11-10

2. Antipsychotic-induced movement disorders: integrative review;REVISTA CIÊNCIAS EM SAÚDE;2022-09-04

3. Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19;ACS Pharmacology & Translational Science;2020-10-14

4. Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients;European Journal of Clinical Pharmacology;2020-09-30

5. Antipsychotic Drugs;Side Effects of Drugs Annual;2018